Eur Rev Med Pharmacol Sci
November 2024
Background: The occurrence of castration-resistant prostate cancer (CRPC) varies in patients with advanced prostate cancer (PCa) undergoing androgen deprivation therapy (ADT). The rate of occurrence of CRPC may be related to the presence of prostate cancer stem cells (CSC). Thus, this study aims to evaluate the presence of CSC markers (CD44 and CD133) in histopathology tissue at the time of diagnosis and their correlation with the occurrence of CRPC in patients with advanced PCa within 2 years of ADT.
View Article and Find Full Text PDFRhabdomyosarcoma of the prostate is rarely found in adults compared to rhabdomyosarcoma in other body regions. In early stage of the tumor, the symptoms are similar to other genitourinary problems, such as dysuria, urinary retention, lower abdominal pain and prostate enlargement. This condition often leads to misdiagnosis and treatment delay because of the tumor's rapid growth.
View Article and Find Full Text PDF